Application | Comment | Organism |
---|---|---|
additional information | model of tauopathy in which, depending on toxic challenges (e.g., oxidative stress, exposure to amyloid peptide, etc.), abnormal phosphorylation of tau by kinases distinct from GSK-3beta leads to progressive accumulation of hyperphosphorylated tau oligomers that are resistant to degradation. Sgg activity is required to prevent the accumulation of high-molecular-weight forms of human tau | Drosophila sp. (in: flies) |
Cloned (Comment) | Organism |
---|---|
coexpression of human tau with a constitutively active form or a dominant-negative form of Sgg | Drosophila sp. (in: flies) |
Protein Variants | Comment | Organism |
---|---|---|
A81T | kinase-null, dominant negative form of Shaggy, leads to the accumulation of hypophosphorylated high-molecular-weight human tau proteins in old transgenic flies. In young transgenic flies expression results in disappearance of monomeric hyperphosphorylated forms of human tau, concomitantly with the accumulation of monomeric hypophosphorylated forms of human tau | Drosophila sp. (in: flies) |
S9A | constitutively active form of Shaggy, drastic upward mobility shift of all monomeric human tau proteins | Drosophila sp. (in: flies) |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Drosophila sp. (in: flies) | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + protein tau | GSK-3beta-mediated hyperphosphorylated forms of tau are degradable by the proteasomal machinery | Drosophila sp. (in: flies) | ADP + protein tau phosphate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
glycogen synthase kinase-3beta | - |
Drosophila sp. (in: flies) |
GSK-3beta | - |
Drosophila sp. (in: flies) |
Sgg | - |
Drosophila sp. (in: flies) |
shaggy/zeste white-3 | - |
Drosophila sp. (in: flies) |